****Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication*******
COMPANY PROFILE
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products....
********HOT STOCK FOR THE DAYS TO COME ON THE BACK OF NEW DEBT REFINANCING AGREEMENT ANNOUNCED MONDAY. RALLY STALLED WITH THE MARKET BUT SHOULD SEE GREATER GAINS IN THE DAYS TO COME. BREAK ABOVE THE 50MA AND MACD CROSS NICE SIGNALS FOR A LONG.
COMPANY PROFILE
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of...
Just a basic analysis don't take as true investment advice. Based off my judgement it seems like a possible long term play.
Lots of institutional players. And I don't want to hear 200% OMG ARE YOU CRAZY. Its a line that spans a zone and says a percentage. DO NOT TAKE AS TRUE GAIN POTENTIAL.
JAGX Stock price is certainly nothing to gleam over, however, the last few days the company is filling out all sorts of documentation to further their projections within the future. Technical analysis, of course, does not appear to be virtuous in this case. as even previous resistance is continued resistance...
Not Investment Advice. For Personal and Educational...
JAGX Showing Resistance At $0.50. Next Resistace Level is $0.61. A Move Upward Is Likely Due To The Stock Being Oversold and Phase Trial Data Expected Sometime Soon! Bullish.
Typical flag pattern
Price break out
Pull back
Show of strength
Trading
get in around the first green candle
profit to the top of the flag
stop loss at the bottom of the flagJAGX
FDA just approved stock. Had a huge pump around .44 before dumping back in the mid .20s.
Volume will continue to grow. Stock will most likely close mid .40s today (3/8/17).
This stock currently has a $7 GAP to fill (From year 2015).
Great set up and pattern. Consolidating at the moment with a positive divergence in buying pressure and momo. Has a big gap to fill and a fairly low float NASDAQ:JAGX
Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
JAGX
